• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T4a 期胃癌肿瘤标志物的预后意义。

Prognostic significance of tumor markers in T4a gastric cancer.

机构信息

Department of Abdominal Surgery, Cancer Hospital, Fudan University, 270 Dong An Road, Shanghai, 200032, People's Republic of China.

出版信息

World J Surg Oncol. 2012 Apr 27;10:68. doi: 10.1186/1477-7819-10-68.

DOI:10.1186/1477-7819-10-68
PMID:22540862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3407764/
Abstract

BACKGROUND

The clinical importance of preoperative tumor markers remain elusive in gastric cancer. The aim of this study was to evaluate the prognostic value of AFP, CEA, CA19-9, and CA50 in T4a stage gastric cancer.

METHODS

Two hundred and seventy-three T4a gastric cancer patients who underwent curative D2 gastrectomy between 1996 and 2005 were evaluated. The correlation between tumor markers and clinicopathologic characteristics and prognostic value of preoperative tumor markers were investigated.

RESULTS

Correlation analysis showed that AFP was associated with Borrmann type (P = 0.010); CEA with sex (P = 0.029), tumors site (P = 0.014), and N stage (P = 0.001); CA19-9 with age (P = 0.047), tumor site (P = 0.011), lymphovascular invasion (P = 0.004), and N stage (P = 0.000); CA50 with age (P = 0.017), tumor site (P = 0.004), tumor size (P = 0.014), and N stage (P = 0.000). Multivariate analysis showed that the positivity of preoperative CEA, CA19-9, and CA50 were major independent poor prognostic factors of patients with T4a stage gastric cancer.

CONCLUSIONS

Preoperative serum tumor marker might be a candidate for the staging system in addition to conventional factors.

摘要

背景

术前肿瘤标志物在胃癌中的临床重要性仍不明确。本研究旨在评估 AFP、CEA、CA19-9 和 CA50 在 T4a 期胃癌中的预后价值。

方法

评估了 1996 年至 2005 年间接受根治性 D2 胃切除术的 273 例 T4a 期胃癌患者。分析了肿瘤标志物与临床病理特征的相关性及术前肿瘤标志物的预后价值。

结果

相关性分析显示,AFP 与 Borrmann 分型相关(P=0.010);CEA 与性别(P=0.029)、肿瘤部位(P=0.014)和 N 分期(P=0.001)相关;CA19-9 与年龄(P=0.047)、肿瘤部位(P=0.011)、血管淋巴管侵犯(P=0.004)和 N 分期(P=0.000)相关;CA50 与年龄(P=0.017)、肿瘤部位(P=0.004)、肿瘤大小(P=0.014)和 N 分期(P=0.000)相关。多因素分析显示,术前 CEA、CA19-9 和 CA50 的阳性表达是 T4a 期胃癌患者的主要独立预后不良因素。

结论

术前血清肿瘤标志物可能是除传统因素之外的另一个分期系统候选标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d47/3407764/31d2da55d65f/1477-7819-10-68-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d47/3407764/13e48efb401a/1477-7819-10-68-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d47/3407764/83f5e78f3539/1477-7819-10-68-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d47/3407764/f0748b7979c9/1477-7819-10-68-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d47/3407764/31d2da55d65f/1477-7819-10-68-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d47/3407764/13e48efb401a/1477-7819-10-68-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d47/3407764/83f5e78f3539/1477-7819-10-68-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d47/3407764/f0748b7979c9/1477-7819-10-68-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d47/3407764/31d2da55d65f/1477-7819-10-68-4.jpg

相似文献

1
Prognostic significance of tumor markers in T4a gastric cancer.T4a 期胃癌肿瘤标志物的预后意义。
World J Surg Oncol. 2012 Apr 27;10:68. doi: 10.1186/1477-7819-10-68.
2
Prognostic significance of tumour markers in Chinese patients with gastric cancer.肿瘤标志物在中国胃癌患者中的预后意义
ANZ J Surg. 2014 Jun;84(6):448-53. doi: 10.1111/j.1445-2197.2012.06287.x. Epub 2012 Sep 26.
3
Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.用于上消化道癌患者诊断、复发监测及预后评估的肿瘤标志物。
Asian Pac J Cancer Prev. 2014;15(23):10267-72. doi: 10.7314/apjcp.2014.15.23.10267.
4
The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.癌胚抗原、CA19.9和CA72.4的血清及胃液水平在胃癌患者中的作用
J Cancer Res Clin Oncol. 1998;124(8):450-5. doi: 10.1007/s004320050198.
5
Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.术前血清中五种肿瘤标志物(癌胚抗原、CA19-9、甲胎蛋白、CA72-4和CA125)水平在胃癌中的预后价值
Hepatogastroenterology. 2014 May;61(131):863-9.
6
Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.胃癌患者中CA72-4与CEA和CA19-9相比的临床意义及预后价值
Dis Markers. 2000;16(3-4):105-10. doi: 10.1155/2000/595492.
7
Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.CEA、CA19-9、AFP 和 CA125 对早期胃癌的诊断和预后价值。
BMC Cancer. 2017 Nov 9;17(1):737. doi: 10.1186/s12885-017-3738-y.
8
Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.胃癌患者肿瘤标志物的临床评估与预后评价。
Int J Biol Markers. 2013 Jun 28;28(2):192-200. doi: 10.5301/jbm.5000023.
9
Clinical Evaluation of Serum Tumor Markers in the Diagnosis of Gastric Adenocarcinoma Staging and Grading.血清肿瘤标志物在胃腺癌分期和分级诊断中的临床评估
J Gastrointest Cancer. 2019 Sep;50(3):525-529. doi: 10.1007/s12029-018-0091-6.
10
Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.CEA、CA19-9、CA72-4和CA125在接受新辅助化疗的胃癌患者中的临床评估
World J Surg Oncol. 2014 Dec 29;12:397. doi: 10.1186/1477-7819-12-397.

引用本文的文献

1
Clinicopathological characteristics and prognosis of adolescents and young adults with gastric cancer after gastrectomy: a propensity score matching analysis.胃癌切除术后青少年和青年患者的临床病理特征及预后:一项倾向评分匹配分析
Front Oncol. 2023 Aug 18;13:1204400. doi: 10.3389/fonc.2023.1204400. eCollection 2023.
2
Construction and Validation of a m7G-Related Gene-Based Prognostic Model for Gastric Cancer.基于m7G相关基因的胃癌预后模型的构建与验证
Front Oncol. 2022 Jun 30;12:861412. doi: 10.3389/fonc.2022.861412. eCollection 2022.
3
Clinical significance of serum tumor markers for advanced gastric cancer with the first-line chemotherapy.

本文引用的文献

1
Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.术前癌胚抗原(CEA)、糖类抗原19-9(CA 19-9)、糖类抗原72-4(CA 72-4)及甲胎蛋白(AFP)水平在胃癌中的预后价值
Adv Ther. 2008 Oct;25(10):1075-84. doi: 10.1007/s12325-008-0100-4.
2
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.血清中微小RNA的特征:用于癌症和其他疾病诊断的一类新型生物标志物。
Cell Res. 2008 Oct;18(10):997-1006. doi: 10.1038/cr.2008.282.
3
Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma.
血清肿瘤标志物在晚期胃癌一线化疗中的临床意义
Transl Cancer Res. 2019 Dec;8(8):2680-2690. doi: 10.21037/tcr.2019.10.27.
4
Co-Expression of LGR5 and CD133 Cancer Stem Cell Predicts a Poor Prognosis in Patients With Gastric Cancer.LGR5 和 CD133 共同表达的癌症干细胞预测胃癌患者预后不良。
Turk J Gastroenterol. 2021 Mar;32(3):261-268. doi: 10.5152/tjg.2021.20108.
5
Carbohydrate Antigen 50: Values for Diagnosis and Prognostic Prediction of Intrahepatic Cholangiocarcinoma.癌抗原 50:用于诊断和预测肝内胆管癌的预后价值。
Medicina (Kaunas). 2020 Nov 16;56(11):616. doi: 10.3390/medicina56110616.
6
A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer.用于胃癌患者的 21 基因支持向量机分类器和 10 基因风险评分系统。
Mol Med Rep. 2020 Jan;21(1):347-359. doi: 10.3892/mmr.2019.10841. Epub 2019 Nov 21.
7
Early postoperative tumor marker responses provide a robust prognostic indicator for N3 stage gastric cancer.术后早期肿瘤标志物反应为N3期胃癌提供了一个强有力的预后指标。
Medicine (Baltimore). 2017 Aug;96(32):e7560. doi: 10.1097/MD.0000000000007560.
8
Clinicopathological features and prognosis of gastric cancer in young patients.青年胃癌患者的临床病理特征及预后
BMC Cancer. 2016 Jul 14;16:478. doi: 10.1186/s12885-016-2489-5.
9
Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma.术前血清CA125、CA19-9和CEA在胃癌中的预后意义。
Oncotarget. 2016 Jun 7;7(23):35423-36. doi: 10.18632/oncotarget.8770.
10
A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.一种用于可切除胃癌的临床预后评分系统,以预测生存情况及从基于紫杉醇或奥沙利铂的辅助化疗中获益的情况。
Drug Des Devel Ther. 2016 Feb 24;10:241-58. doi: 10.2147/DDDT.S88743. eCollection 2016.
胃癌患者肿瘤标志物、细胞外基质、基质金属蛋白酶-9和血管内皮生长因子变化的临床意义
Hepatogastroenterology. 2007 Jul-Aug;54(77):1591-5.
4
Circulating nucleic acids (CNAs) and cancer--a survey.循环核酸与癌症——一项调查
Biochim Biophys Acta. 2007 Jan;1775(1):181-232. doi: 10.1016/j.bbcan.2006.10.001. Epub 2006 Oct 7.
5
Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer.甲胎蛋白(AFP)阳性胃癌的生物学侵袭性
Hepatogastroenterology. 2006 May-Jun;53(69):338-41.
6
Global cancer statistics, 2002.2002年全球癌症统计数据。
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108. doi: 10.3322/canjclin.55.2.74.
7
Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.局部晚期和转移性食管胃癌的多因素预后分析——基于三项多中心随机对照试验个体患者数据的汇总分析
J Clin Oncol. 2004 Jun 15;22(12):2395-403. doi: 10.1200/JCO.2004.08.154.
8
Gastric cancer: establishing predictors of biologic behavior with use of population-based data.胃癌:利用基于人群的数据确定生物学行为的预测指标。
Ann Surg Oncol. 2004 Jun;11(6):629-35. doi: 10.1245/ASO.2004.09.002. Epub 2004 May 18.
9
Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis.淋巴结转移作为胃癌的一个重要预后因素:多元逻辑回归分析
Scand J Gastroenterol. 2004 Apr;39(4):380-4. doi: 10.1080/00365520310008629.
10
Production of embryonal alpha-globulin by transplantable mouse hepatomas.可移植性小鼠肝癌产生胚胎性α-球蛋白
Transplantation. 1963 Apr;1:174-80. doi: 10.1097/00007890-196301020-00004.